Top Markets
#1 Black Phoenix Black Phoenix +354.68%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.84%
#4 OpenEden OpenEden +62.66%
#5 Akedo Akedo +55.50%
#6 BasedHype BasedHype +26.50%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +20.20%
#9 Humanity Humanity +19.73%
#10 Ether.fi Ether.fi +17.74%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
ZIVO Bioscience, Inc. ZIVO Bioscience, Inc.

ZIVO Bioscience, Inc.

ZIVOW
Rank in Stocks #40373
ZIVO Bioscience, Inc. is a research and development firm specializing in the... ZIVO Bioscience, Inc. is a research and development firm specializing in the creation, licensing, and distribution of natural bioactive compounds. These ingredients, derived from its exclusive algal strains, are supplied to manufacturers across the animal health, human health, dietary supplement, and medical food sectors. Active across the biotechnology and agricultural technology domains, ZIVO possesses a comprehensive intellectual property estate. This encompasses unique algal and bacterial strains, novel biologically active molecules and complexes, specialized production and cultivation methodologies, and a suite of patented or patent-pending innovations designed for both human and animal health solutions. The company's offerings address a diverse range of health concerns, such as promoting gut health in poultry, combating bovine mastitis, enhancing joint function in canines, modulating human immune responses, providing algal biomass for direct human consumption, and supporting skin vitality and anti-aging efforts. Previously operating as Health Enhancement Products, Inc., the firm adopted the ZIVO Bioscience, Inc. name in October 2014. Its corporate headquarters are situated in Bloomfield Hills, Michigan.
Share Price
$0.044
Last synced: 2025-12-26
Market Cap
$164.23K
Change (1 day)
-92.00%
Change (1 year)
-92.00%
Country
US
Trade ZIVO Bioscience, Inc. (ZIVOW)

Category

Healthcare
P/E ratio for ZIVO Bioscience, Inc. (ZIVOW)
P/E ratio as of 2026 TTM: 0
According to ZIVO Bioscience, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for ZIVO Bioscience, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 28.05 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 31.14 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 19.30 -
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.